Literature DB >> 11605074

Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.

M A Kuczyk1, C Bokemeyer, J Hartmann, J Schubach, C Walter, S Machtens, R Knuchel, C Kollmannsberger, U Jonas, J Serth.   

Abstract

The p21WAF/Cip and the p27Kip1 genes have been identified as inductors of cell cycle arrest at the G1-checkpoint. Alterations of both genes have been suggested to be involved in the development of a variety of human malignancies due to a loss of critical antiproliferative mechanisms. To evaluate the prognostic importance of these alterations for patients with clinically localized prostate cancer, in 86 specimens (T1-T4) from 86 patients undergoing radical prostatectomy at the Department of Urology at Hannover University Medical School, were investigated. The immunohistochemical expression of the p27Kip1 and p21WAF/Cip protein was correlated to recurrence-free and long-term survival, age, depth of tumour infiltration, histological grade and lymph node status in these patients. After a median follow-up of 71 months (1-198 months), 14 of 20 (70%) patients (Group 1) with loss of p27Kip1 protein expression or a relative amount of < 10% of positively stained tumour cells developed recurrent disease in contrast to 18 of 66 (27%) patients (Group 2) with retained p27Kip1 protein expression (> or = 10% of positively stained tumour cells). The median recurrence-free survival times were 39 (4-134) months and 67 (4-198) months for patients in Groups 1 and 2 (p < 0.01), respectively. In multivariate analysis, loss of p27Kip1 protein expression was identified as the only independent prognostic parameter for recurrence-free survival. Univariate analysis (log-rank test) identified histological grading (p < 0.01) and reactivity for p27Kip1 (p = 0.046) (> or = 10% positivity) as prognostic factors for disease-specific long-term survival. However, during multivariate analysis none of the biological variables investigated retained independent prognostic importance regarding overall survival. Neither a low or a high expression of p21Waf/Cip could be correlated with the clinical prognosis of the patients following radical prostatectomy. This study confirms the independent prognostic value of decreased p27Kip1 protein expression in patients with localized prostate cancer, while a prognostic importance of p21Waf/Cip in addition to established patients' and tumour characteristics like tumour stage and histological grading appears rather unlikely.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11605074     DOI: 10.3892/or.8.6.1401

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.

Authors:  M Horstmann; A S Merseburger; E von der Heyde; J Serth; G Wegener; M Mengel; G Feil; J Hennenlotter; U Nagele; A Anastasiadis; C Bokemeyer; A Stenzl; M Kuczyk
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

2.  Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines.

Authors:  Adebusola A Alagbala; Andrew J McRiner; Kristina Borstnik; Tanzina Labonte; Wonsuk Chang; John G D'Angelo; Gary H Posner; Barbara A Foster
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

Review 3.  p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.

Authors:  Seth A Wander; Dekuang Zhao; Joyce M Slingerland
Journal:  Clin Cancer Res       Date:  2010-10-21       Impact factor: 12.531

Review 4.  The AR dependent cell cycle: mechanisms and cancer relevance.

Authors:  Matthew J Schiewer; Michael A Augello; Karen E Knudsen
Journal:  Mol Cell Endocrinol       Date:  2011-07-12       Impact factor: 4.102

Review 5.  Molecular and genetic prognostic factors of prostate cancer.

Authors:  Arnab Chakravarti; Gary Guotang Zhai
Journal:  World J Urol       Date:  2003-08-09       Impact factor: 4.226

Review 6.  What is the molecular pathology of low-risk prostate cancer?

Authors:  Hemamali Samaratunga; Jonathan I Epstein
Journal:  World J Urol       Date:  2008-04-12       Impact factor: 4.226

Review 7.  Immunopathological prognostic and predictive factors in prostate cancer.

Authors:  E Sivridis; S Touloupidis; A Giatromanolaki
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

Authors:  Likun Li; Cheng Hui Ren; Salahaldin A Tahir; Chengzhen Ren; Timothy C Thompson
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.

Authors:  Panagiotis J Vlachostergios; Foteini Karasavvidou; Grigorios Kakkas; Kassiani Kapatou; Ioannis Gioulbasanis; Danai D Daliani; George Moutzouris; Christos N Papandreou
Journal:  J Negat Results Biomed       Date:  2012-01-05

Review 10.  The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.

Authors:  Naveen Kachroo; Vincent J Gnanapragasam
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-28       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.